Accessing ketamine to treat suicidal thoughts; where Amazon's health care bets are headed next

For people without sufficient support systems and financial resources, a life-altering option may remain out of reach.

September 7, 2023 Check out STAT+

Sponsored By

Dana Ullman for STAT Ketamine can be transformative for people with suicidal thoughts — if they can access it All mental illness treatment that uses IV ketamine is currently off-label, which means it's hard to get insurance to cover the treatments. By Emily Maloney STAT+ | Why the drug industry's opaque warnings on price negotiations fall short Ever since Medicare was given power to negotiate some drug prices, the pharmaceutical industry has argued the move will hurt patients. By Ed Silverman STAT+ | Amazon's chief medical officers on where the company's health care bets are headed next STAT spoke to four of Amazon's chief medical officers about the company's recent plays and how they fit into the company's health care goals. By Katie Palmer Rachel Wisniewski for STAT Not yet free from heroin's grip, an 'honest, funny man' finds his way off the streets To the Prevention Point program in Philadelphia, needle exchange is just one of many social services for people with opioid use disorder. By Rachel Wisniewski STAT+ | In boon for scientists, U.K. strikes deal to join E.U. Horizon research program The U.K. has joined the E.U.'s Horizon research initiative, allowing British scientists to participate in the $100 billion program.  By Andrew Joseph Opinion: How health care systems can protect patients from sexual assault by providers By enacting simple protocols, the institutions we trust with our health and our lives can stop enabling sexual abuse of patients. By Michelle Simpson Tuegel STAT What could fix cancer clinical trials' longstanding diversity problem? When clinical trials lack diversity, it's difficult to understand how findings apply to the populations underrepresented in the trial. By Deborah Balthazar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser